Even for a newly minted Nobel laureate, downtime is hard to find. Just a few weeks after winning the 2025 Nobel Prize in Physiology or Medicine for his discovery of regulatory T cells or Tregs, immunologist Shimon Sakaguchi, M.D., Ph.D., and colleagues have published two new papers demonstrating how rogue T cells can be converted into Tregs to treat a suite of autoimmune diseases.
